摘要 |
The present invention is directed to methods of diagnosing a disease or predicting an increased risk of a disease, such as obesity, obesity-dependent subacute inflammation, atherosclerosis, cardiovascular disease and a metabolic disease, by determining the levels of omentin 1 and 2 protein in a subject, or by determining the levels of omentin 1 and 2 gene expression in a subject. The present invention is also directed to methods of disease treatment using omentin 1 protein and omentin 2 protein.
|
申请人 |
UNIVERSITY OF MARYLAND, BALTIMORE;GONG, DA-WEI;MCLENITHAN, JOHN, C.;SHULDINER, ALAN, R.;YANG, RONG-ZE |
发明人 |
GONG, DA-WEI;MCLENITHAN, JOHN, C.;SHULDINER, ALAN, R.;YANG, RONG-ZE |